The New England journal of medicine 2024 Jul 25
Dual Agonists for Management of Metabolic Dysfunction-Associated Steatohepatitis.
Related Questions
I have several forensic patients who have elevated LFTs and fatty liver on ultrasound, at least in part due to long-term olanzapine use. They are all ...
New comment by at Private Practice ( May 17, 2025)
Anecdotally, I have seen some benefit from adding N-acetylcysteine (1800-2400 mg) for patients who have fatty liver disease. I usually use this as an add-on supplement for pat...